#capricor

1 story

#business #deramiocel #duchenne muscular dystrophy #hopem3 #money #open-label extension #pdufa

Capricor Shares HOPE-3 Data Update
Capricor presents HOPE-3 extension results and deramiocel progress for Duchenne muscular dystrophy treatment.
Seekingalpha · 1m